• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

33.28 +0.67 (+2.07%)
Streaming Delayed Price Updated: 11:37 AM EDT, Aug 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 503,139
Open 32.95
Bid (Size) 33.26 (400)
Ask (Size) 33.31 (400)
Prev. Close 32.61
Today's Range 32.58 - 33.51
52wk Range 22.96 - 43.15
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target ↗
July 30, 2026
There are other reasons to pay attention to Viking Therapeutics. 
Via The Motley Fool
News headline image
Viking Therapeutics Stock Moves Lower: What's Going On? ↗
July 30, 2026
Viking Therapeutics Inc (NASDAQ:VKTX) shares are retreating Thursday despite reporting a narrower second-quarter loss than expected. Here's what you should know. 
Via Benzinga

Performance

YTD
-6.0%
-6.0%
1 Month
-14.0%
-14.0%
3 Month
+4.8%
+4.8%
6 Month
+11.2%
+11.2%
1 Year
-2.0%
-2.0%

More News

Read More
News headline image
Viking Therapeutics Q2 Earnings Call Highlights ↗
July 29, 2026
Via MarketBeat
Topics Earnings
Viking Therapeutics (NASDAQ:VKTX) Q2 Loss Beats Estimates, Shares Edge Lower as Obesity Pipeline Progresses ↗
July 29, 2026
Via Chartmill
News headline image
Wall Street Says Buy the Dip in Viking Therapeutics. Here's the Bull Case ↗
July 28, 2026
Via The Motley Fool
News headline image
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-1 ↗
July 18, 2026
Via The Motley Fool
News headline image
Should You Buy Viking Therapeutics Stock on the Dip? Wall Street Is Screaming "Yes." ↗
July 18, 2026
Via The Motley Fool
News headline image
This GLP-1 Stock Could Double by 2030. Here's Why ↗
July 16, 2026
Via The Motley Fool
News headline image
Should You Buy Eli Lilly Stock? Here's My Honest Take. ↗
July 11, 2026
Via The Motley Fool
News headline image
Here’s How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 10 Years ↗
July 10, 2026
Via Benzinga
News headline image
Is This Biotech Stock a Buy After Its Massive Rally? ↗
July 09, 2026
Via The Motley Fool
News headline image
Is It Too Late to Buy Eli Lilly? ↗
July 08, 2026
Via The Motley Fool
News headline image
CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026? ↗
July 07, 2026
Via The Motley Fool
News headline image
CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
July 06, 2026
Via The Motley Fool
News headline image
Could This Healthcare Stock Help You Build a Real Fortune Over the Next 20 Years? ↗
July 06, 2026
Via The Motley Fool
News headline image
How Much Could $1,000 Invested in Viking Therapeutics Be Worth by 2030? ↗
July 05, 2026
Via The Motley Fool
News headline image
Is Viking Therapeutics Stock Going to $50? Here's What the Bulls and Bears Are Saying ↗
July 04, 2026
Via The Motley Fool
News headline image
Here's Why Viking Therapeutics Stock Surged Higher in June ↗
July 03, 2026
Via The Motley Fool
News headline image
Is Viking Therapeutics Stock Going to $100? ↗
July 01, 2026
Via The Motley Fool
News headline image
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could ↗
June 29, 2026
Via The Motley Fool
News headline image
Dyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
June 26, 2026
Via The Motley Fool
News headline image
Eli Lilly vs Viking Therapeutics: Which GLP-1 Stock Is the Better Buy? ↗
June 23, 2026
Via The Motley Fool
News headline image
Is Viking Therapeutics Stock a No-Brainer Buy Below $35? ↗
June 23, 2026
Via The Motley Fool
News headline image
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk ↗
June 22, 2026
Via The Motley Fool
News headline image
Set It and Forget It: 2 Consumer Stocks to Hold for the Next 20 Years ↗
June 22, 2026
Via The Motley Fool
Topics Artificial Intelligence

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 33.28
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 08/04/26 11:37 AM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.31B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap